Ascivasc Tablets
PDF Leaflet Revision Date: 27 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate hypertension and angina pectoris.
Dosage (summary)
Initial dose of 5 mg once daily, may increase to 10 mg after 10-14 days.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- CYP3A4 inhibitors
- CYP3A4 inducers
- Grapefruit juice
- Lithium
Contraindications
- Hypersensitivity to amlodipine
- Severe hypotension
- Shock
- Unstable angina
- Pregnancy
- Lactation
Common side effects
- Dizziness
- Headache
- Palpitations
- Nausea
- Ankle swelling
Counselling Points
- Take once daily
- Monitor blood pressure
- Avoid grapefruit juice
- Report any severe side effects
Serious warnings
- Caution in heart failure
- Risk of hypotension
- Gradual withdrawal recommended
Important Disclaimer
The Ascivasc Tablets professional information leaflet below is the property of Ascendis Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
